VE1 immunohistochemistry is an adjunct tool for detection of BRAF V600E mutation: Validation in thyroid cancer patients-Reference-Cited by-同舟云学术

VE1 immunohistochemistry is an adjunct tool for detection of BRAF V600E mutation: Validation in thyroid cancer patients

Published:2020-12-10 Issue:2 Volume:35 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Rashid Faiza A.¹,Tabassum Sobia¹,Khan Mosin S.²,Ansari Hifzur R.³,Asif Muhammad⁴,Sheikh Ahmareen K.⁵,Aga Syed⁶^ORCID

Affiliation:

1. Department of Biological Sciences International Islamic University Islamabad Pakistan

2. Government Medical College Srinagar and Associated SMHS and Superspeciality Hospital Srinagar India

3. King Abdullah International Medical Research Center King Saud bin Abdulaziz University for Health Sciences Ministry of National Guard Health Affairs Jeddah Saudi Arabia

4. Department of Histopathology Armed Forces Institute of Pathology central Military Hospital Rawalpindi Pakistan

5. Department of Pathology Pakistan Institute of Medical Sciences Islamabad Pakistan

6. Basic Medical Sciences College of Medicine‐ Jeddah King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center Ministry of National Guard Health Affairs Jeddah Kingdom of Saudi Arabia

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry, medical,Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.23628

Reference41 articles.

1. Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay

2. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology

3. Integrated Genomic Characterization of Papillary Thyroid Carcinoma

4. Mutations of the BRAF gene in human cancer

5. BRAF mutation in thyroid cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review);Experimental and Therapeutic Medicine;2024-02-20

2. Comparison of diagnostic methods for detection of BRAFV600E mutation in ameloblastoma;Journal of Oral Pathology & Medicine;2024-01

3. PUNISHER rs12318065 C>A transversion: a putative somatic driver mutation for poor prognosis in colon cancer;Bioscience Reports;2022-06

4. Prognostic Value of LINC-ROR (rs1942347) Variant in Patients with Colon Cancer Harboring BRAF Mutation: A Propensity Score-Matched Analysis;Biomolecules;2022-04-12

5. Analysis of anti‐apoptotic PVT1 oncogene and apoptosis‐related proteins (p53, Bcl2, PD‐1, and PD‐L1) expression in thyroid carcinoma;Journal of Clinical Laboratory Analysis;2022-04-07